Revolutionizing Bioinformatics: AI-Driven Innovations Shaping the Future of Genomic Research

Bioinformatics market was valued at $12.8 billion in 2024 and is expected to grow at a CAGR of 12.1% from 2025 to 2035, reaching $44.9 billion by the end of the forecast period. Integration of AI techniques such as ML and deep learning with bioinformatics, researchers are overcoming limitations in traditional computational methods. AI algorithms efficiently handle large-scale biological data, enabling more accurate and detailed modeling of biological processes. Furthermore, the cooperation between AI and bioinformatics enables the discovery of novel insights and associations in biological systems. This integrated approach facilitates the identification of biomarkers, drug targets, and disease mechanisms, leading to advancements in personalized medicine and drug development.

Browse the full report description of “Bioinformatics Market Size, Share & Trends Analysis by Product & Services (Knowledge Management Tools, Bioinformatics Platforms, Data Analysis Structural Analysis and Bioinformatics Services), By Application (Metabolomics, Transcriptomics, Proteomics, Genomics and Others) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/bioinformatics-market

AI in precision medicine creates personalized medicines based on a patient's genetic composition, which enhances medication response forecasting and minimizes side effects. AI enhances CRISPR methods in genetic engineering, improving the accuracy of genetic alterations and paving the way for more potent treatments for hereditary illnesses.

Recent Developments

• In December 2023, PlumCare RWE and Fabric Genomics partnered to deliver the Fabric AI platform with the PlumCare RWE FirstSteps newborn genome screening program in Greece. Fabric AI technology for interpretation of the human genome, powered by the Fabric GEM AI algorithm was adapted into the FirstSteps clinical support tool, empowering clinicians to provide timely medical intervention for patients with rare genetic diseases in Greece.

• In December 2023, the DRAIGON initiative, led by EVI, was an effort to combat antimicrobial resistance (AMR) using AI and whole-genome sequencing (WGS). AMR, exacerbated by excessive antimicrobial use, poses a major global health threat, making infections harder to treat.

Key Players and Innovations

The key players in the bioinformatics market are Thermo Fisher Scientific, Inc., GENEWIZ, Illumina, Inc., QIAGEN Bioinformatics, and Agilent Technologies, Inc. Such companies are at the forefront of innovation, constantly improving manufacturing procedures and investigating novel uses for bioinformatics. For instance, in January 2025, Illumina, Inc. announced its collaboration with NVIDIA to advance technology platforms for the analysis and interpretation of multi-omic data, accelerating progress in clinical research, genomics AI development, and drug discovery.

Market Coverage

• The market number available for – 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Product & Services

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Thermo Fisher Scientific, Inc., GENEWIZ, Illumina, Inc., QIAGEN Bioinformatics, Agilent Technologies, Inc., and Others. 

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Bioinformatics Market Report Segment

By Product & Services Phase

• Knowledge Management Tools 
• Bioinformatics Platforms
• Data Analysis Structural Analysis
• Bioinformatics Services 

By Application

• Metabolomics
• Transcriptomics
• Proteomics
• Genomics 
• Others 

Global Bioinformatics Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bioinformatics-market